Product Information
FTI-2628 is a pharmacologic agent that has been shown to have an effect on the cell cycle. It is a small molecule that prevents prenylation of proteins and thereby alters the function of the insulin-like growth factor receptor (IGF-1R). FTI-2628 also inhibits matrix metalloproteinase 13 (MMP-13) expression by blocking transcriptional activation of the gene. This drug has been shown to be effective in animal models for osteoarthritis, as well as inhibiting MMP-13 production in cells from patients with rheumatoid arthritis. FTI-2628 has also been shown to be effective in reducing the size of tumors in mouse models of cancer.
Chemical properties
Technical inquiry about: 3D-FF171686 FTI-2628
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
